Resultats de la cerca - Dirk Reinhardt

Refinar resultats
  1. 1
    Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP

    Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect o... per Dirk Reinhardt

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Redirecting the Immune Microenvironment in Acute Myeloid Leukemia

    Redirecting the Immune Microenvironment in Acute Myeloid Leukemia per Stephanie Sendker, Dirk Reinhardt, Naghmeh Niktoreh

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Pediatric Acute Myeloid Leukemia—Past, Present, and Future

    Pediatric Acute Myeloid Leukemia—Past, Present, and Future per Dirk Reinhardt, Evangelia Antoniou, Katharina Waack

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93

    Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93 per Thomas Lehrnbecher, D. Varwig, Julia Kaiser, Dirk Reinhardt, Thomas Klingebiel, Ursula Creutzig

    Publicat 2003
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Early Deaths and Treatment-Related Mortality in Children Undergoing Therapy for Acute Myeloid Leukemia: Analysis of the Multicenter Clinical Trials AML-BFM 93 and AML-BFM 98

    Early Deaths and Treatment-Related Mortality in Children Undergoing Therapy for Acute Myeloid Leukemia: Analysis of the Multicenter Clinical Trials AML-BFM 93 and AML-BFM 98 per Ursula Creutzig, Martin Zimmermann, Dirk Reinhardt, Michael Dworzak, Jan Starý, Thomas Lehrnbecher

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in MLL-rearranged infant ALL

    Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in MLL-rearranged infant ALL per Matthias Wölfl, Mareike Rasche, Matthias Eyrich, Renate Schmid, Dirk Reinhardt, Paul G. Schlegel

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Newly identified c-KIT receptor tyrosine kinase ITD in childhood AML induces ligand-independent growth and is responsive to a synergistic effect of imatinib and rapamycin

    Newly identified c-KIT receptor tyrosine kinase ITD in childhood AML induces ligand-independent growth and is responsive to a synergistic effect of imatinib and rapamycin per Selim Corbacioglu, Mehtap Kılıç, Mike‐Andrew Westhoff, Dirk Reinhardt, Simone Fulda, Klaus‐Michael Debatin

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin

    Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin per Olaf Witt, Sven Mönkemeyer, Gabi Rönndahl, Bernhard Erdlenbruch, Dirk Reinhardt, Katrin Kanbach, Arnulf Pekrun

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia

    LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia per Stephan Emmrich, Alexandra Streltsov, Franziska Schmidt, Veera Raghavan Thangapandi, Dirk Reinhardt, Jan‐Henning Klusmann

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring

    Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring per Claudia Langebrake, Iris Brinkmann, Andrea Teigler‐Schlegel, Ursula Creutzig, Frank Griesinger, Ulrike Puhlmann, Dirk Reinhardt

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    DNA in extracellular vesicles: from evolution to its current application in health and disease

    DNA in extracellular vesicles: from evolution to its current application in health and disease per Jamal Ghanam, Venkatesh Kumar Chetty, Lennart Barthel, Dirk Reinhardt, P.F. Hoyer, Basant Kumar Thakur

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  12. 12
    Significance of age in acute myeloid leukemia patients younger than 30 years

    Significance of age in acute myeloid leukemia patients younger than 30 years per Ursula Creutzig, Thomas Büchner, Maria Cristina Sauerland, Martin Zimmermann, Dirk Reinhardt, Hartmut Döhner, Richard F. Schlenk

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study

    The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study per Jan‐Henning Klusmann, Dirk Reinhardt, Martin Zimmermann, Bernhard Kremens, Josef Vormoor, Michael Dworzak, Ursula Creutzig, T. Klingebiel

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Residual Disease Monitoring in Childhood Acute Myeloid Leukemia by Multiparameter Flow Cytometry: The MRD-AML-BFM Study Group

    Residual Disease Monitoring in Childhood Acute Myeloid Leukemia by Multiparameter Flow Cytometry: The MRD-AML-BFM Study Group per Claudia Langebrake, Ursula Creutzig, Michael Dworzak, Ondřej Hrušák, Ester Mejstříková, Frank Griesinger, Martin Zimmermann, Dirk Reinhardt

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial

    Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial per Lars Tramsen, Emilia Salzmann‐Manrique, Konrad Bochennek, Thomas Klingebiel, Dirk Reinhardt, Ursula Creutzig, Lillian Sung, Thomas Lehrnbecher

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells

    Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells per Basant Kumar Thakur, Tino Dittrich, Chandra Prakash, Annette Becker, Wolfgang Kuehnau, Jan‐Henning Klusmann, Dirk Reinhardt, Karl Welte

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial

    Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial per Jana Schweitzer, Martin Zimmermann, Mareike Rasche, Christine von Neuhoff, Ursula Creutzig, Michael Dworzak, Dirk Reinhardt, Jan‐Henning Klusmann

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia

    International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia per Thomas Lehrnbecher, Marie‐Chantal Ethier, Theoklis E. Zaoutis, Ursula Creutzig, Alan S. Gamis, Dirk Reinhardt, Richard Aplenc, Lillian Sung

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004

    Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004 per Konrad Bochennek, Angela Haßler, Corinna Perner, Julia Gilfert, Sonja Schöning, Thomas Klingebiel, Dirk Reinhardt, Ursula Creutzig, Thomas Lehrnbecher

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Prospective Validation of a New Method of Monitoring Minimal Residual Disease in Childhood Acute Myelogenous Leukemia

    Prospective Validation of a New Method of Monitoring Minimal Residual Disease in Childhood Acute Myelogenous Leukemia per Daniel Steinbach, Peter Bader, André Willasch, Stephan Bartholomae, Klaus‐Michael Debatin, Martin Zimmermann, Ursula Creutzig, Dirk Reinhardt, Bernd Gruhn

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: